Following non-submission
AWMSG advice |
||
| Status: Not endorsed (Statement of Advice) | ||
In the absence of a submission from the holder of the marketing authorisation, mercaptamine (Cystadrops®) cannot be endorsed for use within NHS Wales for the treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis. |
||
|
||
Medicine details |
||
| Medicine name | mercaptamine (Cystadrops®) | |
| Formulation | eye drops | |
| Reference number | 3316 | |
| Indication | Treatment of corneal cystine crystal deposits in adults and children from 2 years of age with cystinosis |
|
| Company | Recordati Pharmaceuticals Ltd | |
| BNF chapter | Eye | |
| Assessment type | Non-submission | |
| Status | Not endorsed (Statement of Advice) | |
| Date of issue | 25/05/2017 | |